Category: Drug Discovery
Drug Discovery market research reports by DelveInsight
-
Secondary Progressive Multiple Sclerosis (SPMS) - Pipeline Insight, 2024
Secondary Progressive Multiple Sclerosis (SPMS) - Pipeline Insight, 2024 Secondary Progressive Multiple Sclerosis (SPMS) Overview ""Secondary Progressive Multiple Sclerosis (SPMS) Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario ... Read More
-
5-HT4 Partial Agonist - Pipeline Insight, 2024
5-HT4 Partial Agonist - Pipeline Insight, 2024 “5-HT4 Partial Agonist - Pipeline Insight, 2024” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across 5-HT4 Partial Agonist development. The report provides detailed c ... Read More
-
5-HT7 Antagonist - Pipeline Insight, 2024
5-HT7 Antagonist - Pipeline Insight, 2024 “5-HT7 Antagonist - Pipeline Insight, 2024” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across 5-HT7 Antagonist development. The report provides detailed coverage of the ... Read More
-
Chronic Progressive Multiple Sclerosis - Pipeline Insight, 2024
Chronic Progressive Multiple Sclerosis - Pipeline Insight, 2024 Chronic Progressive Multiple Sclerosis Overview ""Chronic Progressive Multiple Sclerosis Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across ... Read More
-
5-HT2C Agonist - Pipeline Insight, 2024
5-HT2C Agonist - Pipeline Insight, 2024 “5-HT2C Agonist - Pipeline Insight, 2024” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across 5-HT2C Agonist development. The report provides detailed coverage of the pipeli ... Read More
-
TGF-Beta-2 Inhibitor - Pipeline Insight, 2024
TGF-Beta-2 Inhibitor - Pipeline Insight, 2024 “TGF-Beta-2 Inhibitor - Pipeline Insight, 2024” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across TGF-Beta-2 Inhibitor development. The report provides detailed cove ... Read More
-
Transitional Cell Carcinoma - Pipeline Insight, 2024
Transitional Cell Carcinoma - Pipeline Insight, 2024 Transitional Cell Carcinoma Overview ""Transitional Cell Carcinoma Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Transitional Cell Carcinoma ... Read More
-
30S Ribosomal Subunit (30S RNA) Inhibitor - Pipeline Insight, 2024
30S Ribosomal Subunit (30S RNA) Inhibitor - Pipeline Insight, 2024 “30S Ribosomal Subunit (30S RNA) Inhibitor - Pipeline Insight, 2024” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across 30S Ribosomal Subunit (30 ... Read More
-
5-HT2 Agonist - Pipeline Insight, 2024
5-HT2 Agonist - Pipeline Insight, 2024 “5-HT2 Agonist - Pipeline Insight, 2024” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across 5-HT2 Agonist development. The report provides detailed coverage of the pipeline ... Read More
-
Thyroid eye disease - Pipeline Insight, 2024
Thyroid eye disease - Pipeline Insight, 2024 Thyroid eye disease Overview ""Thyroid eye disease Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Thyroid eye disease market. A detailed picture of th ... Read More
-
5-HT1 Antagonist - Pipeline Insight, 2024
5-HT1 Antagonist - Pipeline Insight, 2024 “5-HT1 Antagonist - Pipeline Insight, 2024” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across 5-HT1 Antagonist development. The report provides detailed coverage of the ... Read More
-
5-HT1D Agonist - Pipeline Insight, 2024
5-HT1D Agonist - Pipeline Insight, 2024 “5-HT1D Agonist - Pipeline Insight, 2024” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across 5-HT1D Agonist development. The report provides detailed coverage of the pipeli ... Read More
-
5-HT4 Agonist - Pipeline Insight, 2024
5-HT4 Agonist - Pipeline Insight, 2024 “5-HT4 Agonist - Pipeline Insight, 2024” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across 5-HT4 Agonist development. The report provides detailed coverage of the pipeline ... Read More
-
Topical Skin Infection Treatment - Pipeline Insight, 2024
Topical Skin Infection Treatment - Pipeline Insight, 2024 Topical Skin Infection Treatment Overview ""Topical Skin Infection Treatment Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Topical Skin ... Read More
-
Transient Receptor Potential Vanilloid 1 (TRPV-1) Receptor (Capsaicin Receptor or Vanilloid Receptor 1) Antagonist - Pipeline Insight, 2024
Transient Receptor Potential Vanilloid 1 (TRPV-1) Receptor (Capsaicin Receptor or Vanilloid Receptor 1) Antagonist - Pipeline Insight, 2024 “Transient Receptor Potential Vanilloid 1 (TRPV-1) Receptor (Capsaicin Receptor or Vanilloid Receptor 1) Antagonist - Pipeline Insight, 2024” report by DelveIns ... Read More
-
Factor IX - Pipeline Insight, 2024
Factor IX - Pipeline Insight, 2024 DelveInsight’s, “Factor IX - Pipeline Insight, 2024” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Factor IX pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also co ... Read More
-
Acanthamoeba Keratitis - Pipeline Insight, 2024
Acanthamoeba Keratitis - Pipeline Insight, 2024 Acanthamoeba Keratitis Overview ""Acanthamoeba Keratitis Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Acanthamoeba Keratitis market. A detailed p ... Read More
-
Acquired Blepharoptosis - Pipeline Insight, 2024
Acquired Blepharoptosis - Pipeline Insight, 2024 Acquired Blepharoptosis Overview ""Acquired Blepharoptosis Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Acquired Blepharoptosis market. A detail ... Read More
-
Adenosine A1 Receptor Antagonist - Pipeline Insight, 2024
Adenosine A1 Receptor Antagonist - Pipeline Insight, 2024 “Adenosine A1 Receptor Antagonist - Pipeline Insight, 2024” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Adenosine A1 Receptor Antagonist developmen ... Read More
-
Acute Pain- Pipeline Insight, 2024
Acute Pain- Pipeline Insight, 2024 DelveInsight’s, “Acute Pain- Pipeline Insight, 2024” report provides comprehensive insights about 25+ companies and 25+ pipeline drugs in Acute Pain pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also ... Read More
-
Acne - Pipeline Insight, 2024
Acne - Pipeline Insight, 2024 Acne Overview ""Acne Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Acne market. A detailed picture of the Acne pipeline landscape is provided, which includes the di ... Read More
-
Acute Gout Flare - Pipeline Insight, 2024
Acute Gout Flare - Pipeline Insight, 2024 Acute Gout Flare Overview ""Acute Gout Flare Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Acute Gout Flare market. A detailed picture of the Acute Gout ... Read More
-
Acute Social Anxiety Disorder - Pipeline Insight, 2024
Acute Social Anxiety Disorder - Pipeline Insight, 2024 Acute Social Anxiety Disorder Overview ""Acute Social Anxiety Disorder Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Acute Social Anxiety D ... Read More
-
Acute Respiratory Distress Syndrome (ARDS) - Pipeline Insight, 2024
Acute Respiratory Distress Syndrome (ARDS) - Pipeline Insight, 2024 DelveInsight’s, “Acute Respiratory Distress Syndrome – Pipeline Insight, 2024,” report provides comprehensive insights about 120+ companies and 120+ pipeline drugs in Acute Respiratory Distress Syndrome pipeline landscape. It covers ... Read More
-
Acute optic neuritis - Pipeline Insight, 2024
Acute optic neuritis - Pipeline Insight, 2024 DelveInsight’s, “Acute optic neuritis - Pipeline Insight, 2024,” report provides comprehensive insights about 2+ companies and 2+ pipeline drugs in Acute optic neuritis pipeline landscape. It covers the pipeline drug profiles, including clinical and nonc ... Read More
Research Assistance
